Unknown confounders did not bias the treatment effect when improving balance of known confounders in randomized trials

被引:4
|
作者
Kuss, Oliver [1 ,2 ]
Miller, Matthaeus [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, German Diabet Ctr, Inst Biometr & Epidemiol, Leibniz Inst Diabet Res, Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Med Fac, Inst Med Stat, Dusseldorf, Germany
关键词
Randomized controlled trials; Propensity score; Bias; Nonrandomized controlled trial; Confounding variables; Validation study; PROPENSITY-SCORE;
D O I
10.1016/j.jclinepi.2020.06.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: The objective of the study was to measure if improving balance in known and observed confounders by propensity score (PS) matching yields different treatment effect estimates in randomized controlled trials (RCTs), thus indirectly measuring the influence of unknown confounders. Study Design and Setting: This is an analysis of individual patient data of 26 large RCTs and comparison of agreement between PS-matched samples and the RCT results on one hand with the agreement between subsamples of RCTs (with sample sizes equal to the sample sizes of the PS-matched samples) and RCTs by Bland-Altman plots and corresponding intraclass correlation coefficients on the other. Results: We included data on 213 outcomes from 37 treatment comparisons with 193,620 patients from 26 trials. Bland-Altman plots and intraclass correlation coefficients showed better agreement between PS-matched analysis and RCTs than between reduced RCTs and RCTs. Conclusion: We found no indication for a detrimental influence of unknown confounders in PS-matched samples of RCTs. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 18 条
  • [1] Quantifying the bias due to observed individual confounders in causal treatment effect estimates
    Parast, Layla
    Griffin, Beth Ann
    [J]. STATISTICS IN MEDICINE, 2020, 39 (18) : 2447 - 2476
  • [2] Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions
    Kilpatrick, Ryan D.
    Gilbertson, Dave
    Brookhart, M. Alan
    Polley, Eric
    Rothman, Kenneth J.
    Bradbury, Brian D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (02) : 111 - 121
  • [3] Using instrumental variables to disentangle treatment and placebo effects in blinded and unblinded randomized clinical trials influenced by unmeasured confounders
    Elias Chaibub Neto
    [J]. Scientific Reports, 6
  • [4] Using instrumental variables to disentangle treatment and placebo effects in blinded and unblinded randomized clinical trials influenced by unmeasured confounders
    Neto, Elias Chaibub
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [5] The effect of known and unknown confounders on the relationship between air pollution and Covid-19 mortality in Italy: A sensitivity analysis of an ecological study based on the E-value
    Aloisi, Valeria
    Gatto, Andrea
    Accarino, Gabriele
    Donato, Francesco
    Aloisio, Giovanni
    [J]. ENVIRONMENTAL RESEARCH, 2022, 207
  • [6] Inference for the treatment effect in longitudinal cluster randomized trials when treatment effect heterogeneity is ignored
    Bowden, Rhys
    Forbes, Andrew B.
    Kasza, Jessica
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2021, 30 (11) : 2503 - 2525
  • [7] The Effect of Error-in-Confounders on the Estimation of the Causal Parameter When Using Marginal Structural Models and Inverse Probability-of-Treatment Weights: A Simulation Study
    Regier, Michael D.
    Moodie, Erica E. M.
    Platt, Robert W.
    [J]. INTERNATIONAL JOURNAL OF BIOSTATISTICS, 2014, 10 (01): : 1 - 15
  • [8] Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored
    Cecilia-Joseph, Elsa
    Auvert, Bertran
    Broet, Philippe
    Moreau, Thierry
    [J]. BIOMETRICAL JOURNAL, 2015, 57 (03) : 371 - 383
  • [9] Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example
    Yang, Siyun
    Starks, Monique Anderson
    Hernandez, Adrian F.
    Turner, Elizabeth L.
    Califf, Robert M.
    O'Connor, Christopher M.
    Mentz, Robert J.
    Choudhury, Kingshuk Roy
    [J]. CONTEMPORARY CLINICAL TRIALS, 2020, 88
  • [10] THE SIZE AND POWER OF TESTS FOR NO TREATMENT EFFECT IN RANDOMIZED CLINICAL-TRIALS WHEN NEEDED COVARIATES ARE OMITTED
    GAIL, MH
    TAN, WY
    PIANTADOSI, S
    [J]. CONTROLLED CLINICAL TRIALS, 1985, 6 (03): : 231 - 231